Not Yet RecruitingNot Applicable

Investigating the Impact of Early Time-Restricted Eating on Health Outcomes and Quality of Life in Adults With Mild Controlled Asthma Compared to Healthy Adults

United Kingdom36 participantsStarted 2026-02-25

Plain-language summary

This study aims to explore how early time-restricted eating (eTRE) - where all daily meals are eaten within a specific time window - affects health and quality of life in adults. The researchers will compare results between adults with mild, well-controlled asthma and adults without asthma (the control group). Participants can continue to eat their normal food; only the timing of meals will change.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults between 18 and 65 years old. * Control group: individuals without asthma * Asthma group: Have already been diagnosed with controlled mild asthma. * Not following any diet regimen. * Able to read the information pack and give consent in English. Exclusion Criteria: * Moderate to severe asthma * Pregnant * Smoking * Systemic corticosteroids. * History of recent respiratory disease, current chest infection, and collapsed lung. * History of recent surgery (last 2 months), including thoracic, abdominal, and eye surgery. * Being diagnosed with cardiovascular diseases, e.g., unstable angina, a heart attack, uncontrolled high blood pressure, stroke, and aneurysm. * Broken ribs or neck vertebrae. * Cancer. * History of autoimmune diseases * Being diagnosed with an eating disorder. * Overnight shift work

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Lung Function Parameters, FEV1 in Liters (L)

Timeframe: At baseline and after 1 week in each study arm

Lung Function Parameters, FVC in Liters (L)

Timeframe: At baseline and after 1 week in each study arm

Lung Function Parameters, FEV1/ FVC ratio

Timeframe: At baseline and after 1 week in each study arm

Fractional Exhaled Nitric Oxide (FeNO) in parts per billion (ppb)

Timeframe: At baseline and after 1 week in each study arm

Trial details

NCT IDNCT07345572

SponsorDe Montfort University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

Nouf N Alotaibi

+447852689959 P2876983@my365.dmu.ac.uk

View on ClinicalTrials.gov More Asthma Management trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Lung Function Parameters, FEV1 in Liters (L)

Timeframe: At baseline and after 1 week in each study arm

Lung Function Parameters, FVC in Liters (L)

Timeframe: At baseline and after 1 week in each study arm

Lung Function Parameters, FEV1/ FVC ratio

Timeframe: At baseline and after 1 week in each study arm

Fractional Exhaled Nitric Oxide (FeNO) in parts per billion (ppb)

Timeframe: At baseline and after 1 week in each study arm